Recent Updates
Recently added Catalysts
RADX Positive Sentiment Score: 60/100

Appointment of Noel Donnelly as Non-Executive Director

Wednesday, October 2, 2024 1 min read
Key Takeaway: Radiopharm Theranostics has appointed Noel Donnelly as a Non-Executive Director. This strategic move is expected to bolster the company's leadership and governance. Donnelly's experience is anticipated to contribute positively to the company's future endeavors and decision-making processes.

Market Sentiment Analysis

POSITIVE FACTORS

  • Appointment of Noel Donnelly enhances the board's expertise.
  • Strengthens leadership in Radiopharm Theranostics.
  • Positive outlook for future strategic decisions.

Full Press Release Details

• Announcements
• October 2, 2024
Loading Viewer…

More Announcements & Updates

• Announcements
• March 31, 2022
• Announcements
• June 20, 2024
• Announcements
• June 14, 2022
• Announcements
• August 23, 2024

Radiopharm Theranostics Doses First Patient in Phase 1/2a ClinicalStudy of BetaBart (RV-01)

Zacks SCR Analysts Share Their Best Small-Cap Research Ideas for 2026

Radiopharm Theranostics Provides Positive Clinical Updates Across Four Programs

CLINICAL UPDATE AND CAPITAL RAISING OCTOBER 20th, 2025

Radiopharm Theranostics Receives IND approval from US FDA to Initiate Phase I Therapeutic Clinical Study to target B7H3 with Betabart (RV-01)

Dr. Oliver Sartor Appointed to Radiopharm Scientific Advisory Board

• RAD Presentation June 2026
• Zacks Small-Cap Research 2026
• RAD Presentation March 2026
• Radiopharm Theranostics Doses First Patient in Phase 1/2a ClinicalStudy of BetaBart (RV-01)
• Zacks SCR Analysts Share Their Best Small-Cap Research Ideas for 2026
• Zacks Small-Cap Research

Frequently Asked Questions

Who is Noel Donnelly?

Noel Donnelly is the newly appointed Non-Executive Director at Radiopharm Theranostics.

What is the significance of Donnelly's appointment?

Donnelly's appointment is expected to enhance the company's leadership and governance.

What role does a Non-Executive Director play?

A Non-Executive Director provides independent oversight and strategic guidance to the board.

When was the appointment announced?

The appointment of Noel Donnelly was announced on October 2, 2024.

Tags: RADX Viatris Investor Conferences Healthcare Radiopharm Theranostics Noel Donnelly Non-Executive Director leadership
Last updated: Oct 2, 2024